Exome-wide Analysis Identifies Three Low-Frequency Missense Variants Associated with Pancreatic Cancer Risk in Chinese Populations

Jiang Chang,Jianbo Tian,Ying Zhu,Rong Zhong,Kan Zhai,Jiaoyuan Li,Juntao Ke,QiangQiang Han,Jiao Lou,Wei Chen,Beibei Zhu,Na Shen,Yi Zhang,Yajie Gong,Yang,Danyi Zou,Xiating Peng,Zhi Zhang,Xuemei Zhang,Kun Huang,Ming Yang,Li Wang,Chen Wu,Dongxin Lin,Xiaoping Miao

DOI: https://doi.org/10.1038/s41467-018-06136-x

IF: 16.6

2018-01-01

Nature Communications

Abstract:Germline coding variants have not been systematically investigated for pancreatic ductal adenocarcinoma (PDAC). Here we report an exome-wide investigation using the Illumina Human Exome Beadchip with 943 PDAC cases and 3908 controls in the Chinese population, followed by two independent replicate samples including 2142 cases and 4697 controls. We identify three low-frequency missense variants associated with the PDAC risk: rs34309238 in PKN1 (OR = 1.77, 95% CI: 1.48–2.12, P = 5.35 × 10 −10 ), rs2242241 in DOK2 (OR = 1.85, 95% CI: 1.50–2.27, P = 4.34 × 10 −9 ), and rs183117027 in APOB (OR = 2.34, 95% CI: 1.72–3.16, P = 4.21 × 10 −8 ). Functional analyses show that the PKN1 rs34309238 variant significantly increases the level of phosphorylated PKN1 and thus enhances PDAC cells' proliferation by phosphorylating and activating the FAK/PI3K/AKT pathway. These findings highlight the significance of coding variants in the development of PDAC and provide more insights into the prevention of this disease.